This tumor type lacks the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) gene amplification, rendering it resistant to conventional chemotherapy that depends on the presence of these receptors. Here, ESR1 is linked to neoplasm.